- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hikma Pharmaceuticals PLC ADR (HKMPY)
Hikma Pharmaceuticals PLC ADR stock price live, this page displays OTC HKMPY stock exchange data. View the HKMPY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hikma Pharmaceuticals PLC ADR real time stock price chart below.
What Is the Hikma Pharmaceuticals PLC ADR Stock Price Today?
The Hikma Pharmaceuticals PLC ADR stock price today is 45.4.
What Is the Stock Symbol for Hikma Pharmaceuticals PLC ADR?
The stock symbol for Hikma Pharmaceuticals PLC ADR is "HKMPY."
What Stock Exchange Does Hikma Pharmaceuticals PLC ADR Trade On?
Hikma Pharmaceuticals PLC ADR is listed and trades on the OTC Markets stock exchange.
Is Hikma Pharmaceuticals PLC ADR a Good Stock to Buy?
Determining whether Hikma Pharmaceuticals PLC ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HKMPY quote. (ISIN: US4312881091)
What Is the Hikma Pharmaceuticals PLC ADR Stock Price Today?
The Hikma Pharmaceuticals PLC ADR stock price today is 45.4.
What Is the Stock Symbol for Hikma Pharmaceuticals PLC ADR?
The stock symbol for Hikma Pharmaceuticals PLC ADR is "HKMPY."
What Stock Exchange Does Hikma Pharmaceuticals PLC ADR Trade On?
Hikma Pharmaceuticals PLC ADR is listed and trades on the OTC Markets stock exchange.
Is Hikma Pharmaceuticals PLC ADR a Good Stock to Buy?
Determining whether Hikma Pharmaceuticals PLC ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HKMPY quote. (ISIN: US4312881091)
45.4
-0.9(-1.86%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
45.4
45.4
52 wk Range
31.8
50.6
HKMPY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
45.445.4
52 wk Range
31.850.6
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.70%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.70%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HKMPY Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 10 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Earnings
Latest Release
Aug 06, 2026
EPS / Forecast
1.02 / --
Revenue / Forecast
1.73B / --
Compare HKMPY to Peers and Sector
Metrics to compare | HKMPY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHKMPYPeersSector | |
|---|---|---|---|---|
P/E Ratio | 12.0x | 23.5x | −0.4x | |
PEG Ratio | 2.26 | −0.10 | 0.00 | |
Price/Book | 1.8x | 2.1x | 2.6x | |
Price / LTM Sales | 1.4x | 2.8x | 3.1x | |
Upside (Analyst Target) | - | 5.3% | 48.4% | |
Fair Value Upside | Unlock | 15.0% | 6.5% | Unlock |
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Hikma Pharma ADR (HKMPY) Stock Price Today?
The Hikma Pharma ADR stock price today is 45.4 USD.
What Stock Exchange Does Hikma Pharma ADR Trade On?
Hikma Pharma ADR is listed and trades on the OTC Markets.
What Is the Stock Symbol for Hikma Pharma ADR?
The stock symbol for Hikma Pharma ADR is "HKMPY."
Does Hikma Pharma ADR Pay Dividends? What’s The Current Dividend Yield?
The Hikma Pharma ADR dividend yield is 3.7%.
What Is the Hikma Pharma ADR Market Cap?
As of today, Hikma Pharma ADR market cap is 4.67B USD.
What Is Hikma Pharma ADR's Earnings Per Share (TTM)?
The Hikma Pharma ADR EPS (TTM) is 1.8.
From a Technical Analysis Perspective, Is HKMPY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Hikma Pharma ADR Stock Split?
Hikma Pharma ADR has split 0 times.
How Many Employees Does Hikma Pharma ADR Have?
Hikma Pharma ADR has 9500 employees.
What is the current trading status of Hikma Pharma ADR (HKMPY)?
As of Aug 14, 2026, Hikma Pharma ADR (HKMPY) is trading at a price of 45.4 USD, with a previous close of 46.2 USD. The stock has fluctuated within a day range of 45.4 USD to 45.4 USD, while its 52-week range spans from 31.8 USD to 50.6 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.